Preparation, characterization, and pharmacokinetics of sterically stabilized nimodipine-containing liposomes

Drug Development and Industrial Pharmacy

Volumn 32, Issue 2, 2006, Pages 219-227

  Yang, Danbo ^a   Zhu, Jiabi ^a,b   Zheng, Ying ^a   Ge, Liang ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b Department of Pharmaceutics ^*  (China)

Author keywords

Liposomes; Lyophilization; Nimodipine; Pharmacokinetics

Indexed keywords

CHOLESTEROL; COSURFACTANT; DEOXYCHOLATE SODIUM; LIPOSOME; NIMODIPINE; PHOSPHATIDYLCHOLINE; POLOXAMER;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG SOLUBILITY; DRUG STABILITY; DRUG SYNTHESIS; ENCAPSULATION; FREEZE DRYING; HALF LIFE TIME; MALE; NONHUMAN; PARAMETER; PARTICLE SIZE; RABBIT;

ANIMALS; AREA UNDER CURVE; CALCIUM CHANNEL BLOCKERS; CHEMISTRY, PHARMACEUTICAL; CHOLESTEROL; DRUG STABILITY; FREEZE DRYING; HALF-LIFE; INFUSIONS, INTRAVENOUS; LIPOSOMES; METABOLIC CLEARANCE RATE; NIMODIPINE; PARTICLE SIZE; PHOSPHATIDYLCHOLINES; RABBITS;

EID: 33645008153     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040500466270     Document Type: Article

References (30)

1. Castile, J. D., Taylor, K. M., & Buckton, G. (2001). The influence of incubation temperature and surfactant concentration on the interaction between dimyristoylphosphatidylcholine liposomes and poloxamer surfactants. Int J Pharm., 221(1-2), 197-209.
2. Daemen, T., Regts, J., Meesters, M., Ten Kate, M. T., Bakker-Woudenberg, I. A. J. M., & Scherphof, G. L. (1997). Toxicity of doxorubicin entrapped within long-circulating liposomes. J. Control. Release, 44(1), 1-9.
3. Deamer, D., & Bangham, A. D. (1976). Large volume liposomes by an ether vaporization method. Biochem Biophys Acta., 443(3), 629-634.
4. Dorsch, N. W. (2002). Therapeutic approaches to vasospasm in subarachnoid hemorrhage. Curr. Opin. Crit. Care., 8(2), 128-133.
5. Feng, S., & Yang, X. (2003). Nursing drip nimodipine injection. Chin CJCM., 3(16), 1460.
6. Glavas-Dodov, M., Fredro-Kumbaradzi, E., Goracinova, K., Simonoska, M., Calis, S., Trajkovic-Jolevska, S., & Hincal, A. A. (2005). The effects of lyophilization on the stability of liposomes containing 5-FU. Int J Pharm., 291(1-2), 79-86.
7. Grunenberg, A., Keil, B., & Henck, J. O. (1995). Polymorphism in binary mixture, as exemplified by nimodipine. Int. J. Pharm., 118(1), 11-21.
8. Harrigan, P. R., Madden, T. D., & Cullis, P. R. (1990). Protection of liposomes during dehydration or freezing. Chem. Phys. Lipids, 52(2), 139-149.
9. He, Z., Zhong, D., Chen, X., Liu, X., Tang, X., & Zhao, L. (2004). Development of a dissolution medium for nimodipine tablets based on bioavailability evaluation. Eur. J. Pharm. Sci., 21(4), 487-491.
10. Kim, B. D., Na, K., & Choi, H. K. (2005). Preparation and characterization of solid lipid nanoparticles (SLN) made of cacao butter and curdlan. Eur. J. Pharm. Sci., 24(2-3), 199-205.
11. Laslo, A. M., Eastwood, J. D., Urquhart, B., Lee, T. Y., & Freeman, D. (2004). Subcutaneous administration of nimodipine improves bioavailability in rabbits. J Neurosci Methods., 139(2), 195-201.
12. Madden, T. D., Bally, M. B., Hope, M. J., Cullis, P. R., Schieren, H. P., & Janoff, A. S. (1985). Protection of large unilamellar vesicles by trehalose during dehydration, retention of vesicle contents. Biochim. Bophys. Acta., 817(1), 67-74.
13. Mayberg, M. R. (1998). Cerebral vasospasm. Neurosurg. Clin. N Am., 9(3), 615-627.
14. Memoli, A., Palermiti, L. G., Travagli, V., & Alhaique, F. (1995). Egg and soya phospholipids - sonication and dialysis: A study on liposome characterization. Int. J. Pharm., 117(2), 159-163.
15. Mi, Z., & Burke, T. G. (1994). Marked interspecies variations concerning the interactions of camptothecin with serum abumins, a frequency-doman fluorescence spectroscopic study. Biochemistry, 33(42), 12540-12545.
16. Perez-Trepichio, A. D., & Jones, S. C. (1996). Evaluation of a novel nimodipine delivery system in conscious rats that allows sustained release for 24 h. J Neurosci Methods., 68(2), 297-301.
17. Qi, J., Ma, K., Jin, G., & Hu, L. (2003). Absorption of nimodipine parenteral solution by infusion set in intravenous administration via micro-pump. Chin JMAP., 20(5), 389-391.
18. Ragno, G., Veronico, M., & Vetuschi, C. (1995). Analysis of nimodipine and its photodegradation product by derivative spectrophotometry and gas chromatography. Int J Pharm., 119(1), 115-119.
19. Ramsch, K. D., Ahr, G., Tettenborn, D., & Auer, L. M. (1985). Overview on pharmacokinetics of nimodipine in heathy volunteers and in patients with subarachnoid hemorrhage. Neurochirurgia (Stuttg)., 28(Suppl 1), 74-78.
20. Schneider, T., Sachse, A., Rößling, G., & Brandl, M. (1995). Generation of contrast-carrying liposomes of defined size with a new continuous high pressure extrusion method. Int. J. Pharm., 117(1), 1-12.
21. Schlossmann, K., Zembrod, A., Kazda, S. (May 15, 1985). Parenteral dihydropyridine liposome formulation. DE Patent 3,339,861.
22. Thomson, P. D. R., & Montvale, N. J. (2003). Physician Desk Reference, AmBisome®, liposomal amphotericin B; Gilead, (NeXstar), DaunoXome®, liposomal Daunorubicin, Gilead (NeXstar); Doxil®, liposomal doxorubicin, Alza (Sequus), 57th ed.
23. Toyota, B. D. (1999). The efficacy of an abbreviated course of nimodipine in patients with good-grade aneurysmal subarachnoid hemorrhage. J. Neurosurg., 90(2), 203-6.
24. Ulmius, J., Lindblom, G., Wennerstrom, H., Johansson, L. B., Fontell, K., Soderman, O., & Arvidson, G. (1982). Molecular organization in the liquid - crystalline phases of lecithin - sodium cholate-water systems studied by nuclear magnetic resonance. Biochemistry., 21(7), 1553-60.
25. Vemuri, S., & Rhodes, C. T. (1995). Preparation and characterization of liposomes as therapeutic delivery systems, a review. Pharm Acta Helv., 70(2), 95-111.
26. Vinge, E., Andersson, K. E., Brandt, L., Ljunggren, B., Nilsson, L. G., & Rosendal-Helgesen, S. (1986). Pharmacokinetics of nimodipine in patients with aneurysmal subarachnoid haemorrhage. Eur. J. Clin. Pharmacol., 30(4), 421-425.
27. Zhang, J. A., & Pawelchak, J. (2000). Effect of pH, ionic strength and oxygen burden on the chemical stability of EPC/cholesterol liposomes under accelerated conditions. Part 1, Lipid hydrolysis. Euro. J. Phar. Biopharm., 50(3), 357-364.
28. Zhang, Q., & Jang, X. (2005). Effects of intranasal administration of n imodipine on cerebral hemodynamics of dogs. Acta Pharm. Sin., 40(5), 466-469.
29. Zhang, Q., Jang, X., Jang, W., Lu, W., Su, L., & Shi, Z. (2004). Preparation of nimodipine-loaded microemulsion for intranasal delivery and evaluation on the targeting efficiency to the brain. Int J Pharm., 275(1-2), 85-96.
30. Zhang, Q., Yie, G., Li, Y., Yang, Q., & Nagai, T. (2000). Studies on the cyclosporin A loaded stearic acid nanoparticles. Int J Pharm., 200(2), 153-159.